Olanzapine Effects on Lipid Metabolism
Variable analysis
- Diet (medium-fat or cholecalciferol-supplemented medium-fat)
- Olanzapine treatment (10 mg/kg, orally administered or vehicle)
- Serum total cholesterol levels
- Serum LDL cholesterol levels
- Serum HDL cholesterol levels
- Serum triglyceride levels
- Cholecalciferol content in the diets (1.37 IU/g in medium-fat diet, 200 IU/g in cholecalciferol-supplemented medium-fat diet)
- Olanzapine administration vehicle (0.5% carboxymethyl cellulose solution)
- Mouse strain (not specified)
- Mouse age (not specified)
- Mouse sex (not specified)
- Blood collection method (cardiac puncture)
- Serum isolation method (centrifugation)
- Cholesterol and triglyceride measurement methods (LabAssay Cholesterol kit and services by Nagahama Lifescience)
- None specified
- Vehicle (0.5% carboxymethyl cellulose solution) group
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!